Aortic Arch Interruption & Motor Regression: 22q11.2 Syndrome & JIA

A one-year-old girl with 22q11.2 deletion syndrome experienced developmental regression of motor skills following surgical repair of an interrupted aortic arch and ventricular septal defect, according to a case report published in Cureus. The case highlights a rare complication in patients with this genetic syndrome and congenital heart defects, as developmental regression is infrequently observed following successful cardiac repair.

The patient’s interrupted aortic arch (IAA) was determined to be caused by a chromosome 22q11.2 deletion, identified through whole-exome sequencing, as reported on December 29, 2024. IAA type B is frequently associated with 22q11.2 deletion syndrome, affecting approximately 50% of individuals with the condition, according to research published in PMC.

22q11.2 Deletion Syndrome and Congenital Heart Defects

22q11.2 deletion syndrome (22q11.2DS), also known as DiGeorge syndrome, is a genetic disorder caused by a missing piece of chromosome 22. This deletion can lead to a wide range of health problems, including congenital heart defects, immune deficiencies, developmental delays, and learning difficulties. Interrupted aortic arch, a rare but life-threatening congenital heart defect, occurs when the aorta, the main artery carrying blood from the heart, is incomplete.

The aorta’s interruption between the left carotid and left subclavian arteries is characteristic of the condition, as detailed by the 22Q.org resource. Without surgical correction, IAA is often fatal in the neonatal period. While developmental delay is a common feature of 22q11.2DS and congenital heart disease, the reported case is notable because it describes a regression in motor development after initial progress following surgery.

Case Details and Findings

The patient in the Cureus report initially demonstrated reasonable motor development after the repair of her interrupted aortic arch and ventricular septal defect. However, this progress was followed by a noticeable regression in her motor abilities. The report does not specify the nature or extent of the regression, but it indicates that it occurred despite the successful surgical intervention.

The case also notes the development of juvenile idiopathic arthritis in the patient, raising the possibility of an autoimmune component contributing to the developmental regression. The interplay between 22q11.2DS, congenital heart disease, and autoimmune conditions is complex and not fully understood.

Implications and Future Research

This case underscores the importance of careful monitoring of motor development in children with 22q11.2DS who undergo surgical repair of congenital heart defects. While surgical correction can improve cardiac function, it does not necessarily eliminate the risk of neurodevelopmental complications. The report suggests that developmental regression, though rare, should be considered as a potential outcome in these patients.

Further research is needed to understand the mechanisms underlying developmental regression in this population. Investigating the potential role of autoimmune processes, as suggested by the presence of juvenile idiopathic arthritis in this case, could be particularly valuable. Improved outcomes in patients with 22q11.2DS and IAA are possible with early intervention and comprehensive care, but ongoing monitoring for neurodevelopmental changes remains crucial.

The findings emphasize the need for an interdisciplinary approach to the care of children with 22q11.2DS and congenital heart defects, involving cardiologists, geneticists, neurologists, and developmental specialists. Early identification and management of potential complications, including developmental regression, can help optimize long-term outcomes for these patients.